| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 474 | 2021 |
| Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates SE Ohmit, MG Thompson, JG Petrie, SN Thaker, ML Jackson, ... Clinical infectious diseases 58 (3), 319-327, 2014 | 390 | 2014 |
| Comparative efficacy of inactivated and live attenuated influenza vaccines AS Monto, SE Ohmit, JG Petrie, E Johnson, R Truscon, E Teich, J Rotthoff, ... New England Journal of Medicine 361 (13), 1260-1267, 2009 | 358 | 2009 |
| Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type HQ McLean, MG Thompson, ME Sundaram, BA Kieke, M Gaglani, ... The Journal of infectious diseases 211 (10), 1529-1540, 2015 | 319 | 2015 |
| Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection SE Ohmit, JG Petrie, RT Cross, E Johnson, AS Monto The Journal of infectious diseases 204 (12), 1879-1885, 2011 | 307 | 2011 |
| Antibody to influenza virus neuraminidase: an independent correlate of protection AS Monto, JG Petrie, RT Cross, E Johnson, M Liu, W Zhong, M Levine, ... The Journal of infectious diseases 212 (8), 1191-1199, 2015 | 294 | 2015 |
| Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains JJ Treanor, HK Talbot, SE Ohmit, LA Coleman, MG Thompson, PY Cheng, ... Clinical infectious diseases 55 (7), 951-959, 2012 | 294 | 2012 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 286 | 2022 |
| 2014–2015 influenza vaccine effectiveness in the United States by vaccine type RK Zimmerman, MP Nowalk, J Chung, ML Jackson, LA Jackson, ... Clinical Infectious Diseases, ciw635, 2016 | 280 | 2016 |
| Early estimates of seasonal influenza vaccine effectiveness-United States, January 2015 B Flannery, J Clippard, RK Zimmerman, MP Nowalk, ML Jackson, ... MMWR Morb Mortal Wkly Rep 64 (1), 10-5, 2015 | 257 | 2015 |
| Influenza vaccine effectiveness in the community and the household SE Ohmit, JG Petrie, RE Malosh, BJ Cowling, MG Thompson, DK Shay, ... Clinical infectious diseases 56 (10), 1363-1369, 2013 | 225 | 2013 |
| Intraseason waning of influenza vaccine protection: evidence from the US influenza vaccine effectiveness network, 2011–2012 through 2014–2015 JM Ferdinands, AM Fry, S Reynolds, JG Petrie, B Flannery, ML Jackson, ... Clinical Infectious Diseases 64 (5), 544-550, 2017 | 208 | 2017 |
| Influenza vaccine effectiveness against 2009 pandemic influenza A (H1N1) virus differed by vaccine type during 2013–2014 in the United States M Gaglani, J Pruszynski, K Murthy, L Clipper, A Robertson, M Reis, ... The Journal of infectious diseases 213 (10), 1546-1556, 2016 | 194 | 2016 |
| Outpatient antibiotic prescribing for acute respiratory infections during influenza seasons FP Havers, LA Hicks, JR Chung, M Gaglani, K Murthy, RK Zimmerman, ... JAMA network open 1 (2), e180243-e180243, 2018 | 193 | 2018 |
| Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan AS Monto, PM DeJonge, AP Callear, LA Bazzi, SB Capriola, RE Malosh, ... The Journal of infectious diseases 222 (1), 9-16, 2020 | 185 | 2020 |
| The doctrine of original antigenic sin: separating good from evil AS Monto, RE Malosh, JG Petrie, ET Martin The Journal of infectious diseases 215 (12), 1782-1788, 2017 | 160 | 2017 |
| Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures JG Petrie, SE Ohmit, E Johnson, RT Cross, AS Monto Journal of Infectious Diseases 203 (9), 1309-1315, 2011 | 142 | 2011 |
| Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 US communities MR Griffin, AS Monto, EA Belongia, JJ Treanor, Q Chen, J Chen, ... PloS one 6 (8), e23085, 2011 | 135 | 2011 |
| Donor to recipient transmission of SARS‐CoV‐2 by lung transplantation despite negative donor upper respiratory tract testing DR Kaul, AL Valesano, JG Petrie, R Sagana, D Lyu, J Lin, E Stoneman, ... American Journal of Transplantation 21 (8), 2885-2889, 2021 | 123 | 2021 |
| Seasonal effectiveness of live attenuated and inactivated influenza vaccine JR Chung, B Flannery, MG Thompson, M Gaglani, ML Jackson, AS Monto, ... Pediatrics 137 (2), 2016 | 113 | 2016 |
